Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AMO’s Tecnis

This article was originally published in The Gray Sheet

Executive Summary

CMS seeks comments by Oct. 31 on whether Advanced Medical Optics' Tecnis intraocular lens should qualify for a new technology IOL payment under the ambulatory surgical system. AMO submitted additional information on the clinical relevance of Tecnis' increased contrast sensitivity this year, after CMS rejected the firm's application in 2004 for failing to show that patients benefited from the design improvements. AMO also provided more studies and a meta-analysis. If CMS approves the application, Tecnis will be reimbursed at a $50 premium over standard IOLs...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022737

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel